Can I Get TRT Online? A Guide to the Safe Process

At a glance
- Eligibility threshold / total testosterone below 300 ng/dL on two separate morning draws (Endocrine Society guideline)
- Required labs at baseline / total T, free T, LH, FSH, hematocrit, PSA, comprehensive metabolic panel
- Time to first prescription / typically 5 to 14 business days after labs are reviewed
- Most common online formulations / testosterone cypionate injection, testosterone enanthate injection, transdermal gel (AndroGel 1.62%, Testim)
- DEA Schedule / testosterone is a Schedule III controlled substance under 21 U.S.C. § 812
- Monitoring frequency / hematocrit and total T every 3 to 6 months for the first year per Endocrine Society guidelines
- Red flag / any site offering testosterone without a lab requirement or licensed physician sign-off
- Fertility impact / exogenous testosterone suppresses LH and FSH, reducing sperm production in most men within weeks
- PSA watch / baseline PSA required before starting; recheck at 3 to 6 months per American Urological Association
- Average dose range / testosterone cypionate 50 to 200 mg IM or subcutaneous every 1 to 2 weeks
Is Online TRT Medically Legitimate?
Online TRT is medically legitimate when delivered through a licensed telehealth provider who follows the same diagnostic and prescribing standards required of an in-person clinic. The Endocrine Society's 2018 Clinical Practice Guideline on male hypogonadism states that treatment should begin only after "unequivocally low serum testosterone concentrations" are confirmed on at least two morning measurements [1]. A compliant online clinic replicates that standard digitally.
What Federal Law Says
Testosterone is a Schedule III controlled substance under the Controlled Substances Act [2]. That classification means it can be prescribed only by a DEA-registered practitioner after a legitimate patient-physician relationship has been established. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 originally required an in-person visit before any controlled substance could be prescribed via telemedicine [3]. During the COVID-19 public health emergency, the DEA issued temporary waivers allowing telehealth prescribing of controlled substances without a prior in-person visit. As of 2025, the DEA's proposed Special Registration rules would formalize a pathway for telemedicine prescribing of Schedule III substances for established patients; practitioners must track these regulatory updates closely [4].
What a Legitimate Online Clinic Must Do
A compliant telehealth TRT provider will require: a structured intake questionnaire covering symptoms, medications, and comorbidities; a physician or advanced practice provider (APP) video or synchronous consultation; lab work ordered through a CLIA-certified lab; and documented informed consent covering fertility effects, erythrocytosis risk, and cardiovascular considerations. If a website skips any of these steps, it is operating outside standard of care.
Who Qualifies for TRT?
Qualification requires both biochemical evidence of low testosterone and symptoms consistent with hypogonadism. Labs alone are not sufficient, and symptoms alone are not sufficient.
Biochemical Criteria
The Endocrine Society defines male hypogonadism as a total testosterone below 300 ng/dL (10.4 nmol/L) confirmed on two separate early-morning (before 10 a.m.) blood draws from a reliable assay [1]. Some men present with total T in the low-normal range but have elevated sex hormone-binding globulin (SHBG), driving free testosterone low. In those cases, free testosterone measurement by equilibrium dialysis may support diagnosis. The American Association of Clinical Endocrinology (AACE) 2022 position statement similarly endorses free testosterone measurement when total T is borderline [5].
Symptom Criteria
Classic symptoms of hypogonadism include reduced libido, erectile dysfunction, decreased energy, loss of muscle mass, increased adiposity, depressed mood, and reduced bone mineral density. The Androgen Deficiency in Aging Males (ADAM) questionnaire and the AMS (Aging Males' Symptoms) scale are validated screening tools used by many telehealth providers before lab work is ordered [6].
Who Is Excluded
Men with untreated severe obstructive sleep apnea, active prostate or breast cancer, hematocrit above 50%, uncontrolled heart failure, or a desire for near-term fertility are generally excluded from TRT initiation per Endocrine Society guidelines [1]. Men seeking fertility preservation may instead be candidates for clomiphene citrate or human chorionic gonadotropin (hCG) therapy, which stimulate endogenous testosterone production without suppressing the hypothalamic-pituitary-gonadal (HPG) axis.
The Step-by-Step Online TRT Process
Getting TRT online follows a defined sequence. Reputable clinics do not deviate from it.
Step 1: Intake and Symptom Screening
You complete a detailed medical history form covering current medications, prior testosterone use, cardiovascular history, sleep apnea status, prostate history, and fertility goals. Many clinics also administer a validated symptom score such as the ADAM questionnaire [6]. This intake is reviewed by a licensed clinician before labs are ordered.
Step 2: Baseline Laboratory Work
The clinician orders a panel through a CLIA-certified national lab network (LabCorp or Quest Diagnostics are the most common). Required baseline labs for TRT evaluation typically include:
- Total testosterone (two morning draws, at least one week apart)
- Free testosterone (equilibrium dialysis preferred)
- Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to distinguish primary from secondary hypogonadism
- Sex hormone-binding globulin (SHBG)
- Complete blood count (CBC) with hematocrit
- Comprehensive metabolic panel (CMP)
- Prostate-specific antigen (PSA)
- Estradiol (baseline)
- Thyroid-stimulating hormone (TSH) to rule out thyroid-mediated symptoms
A 2020 analysis published in JAMA Internal Medicine found that 25% of men initiating TRT in a large commercial database had not had testosterone measured in the prior 12 months, highlighting how often the diagnostic workup is skipped outside structured programs [7].
Step 3: Physician Consultation
After labs are resulted, a DEA-registered physician or APP reviews your values in a synchronous video or phone visit. This is where diagnosis is confirmed, alternative causes of symptoms are ruled out, and treatment options are discussed. Expect a conversation about formulation choices, injection technique (if applicable), and the timeline for monitoring. The visit typically runs 20 to 30 minutes for a new patient.
Step 4: Prescription and Dispensing
If TRT is indicated, the prescribing clinician sends the prescription electronically to a licensed compounding pharmacy or a 503B outsourcing facility, or to a retail pharmacy for brand-name products. Common formulations available through online TRT clinics include:
- Testosterone cypionate (100 to 200 mg/mL solution for injection): the most widely prescribed form in the United States, given IM or subcutaneously every 7 to 14 days
- Testosterone enanthate (200 mg/mL): similar pharmacokinetics to cypionate, slightly shorter half-life
- Testosterone gel (AndroGel 1.62%, Testim, Vogelxo): applied daily to shoulders or upper arms; FDA-approved formulations carry a Black Box Warning regarding secondary exposure in children and women [8]
- Testosterone pellets (Testopel): inserted subcutaneously every 3 to 6 months; less common via telehealth due to the in-office procedure requirement
Compounded testosterone cypionate from a 503A pharmacy is legal when prescribed by a licensed practitioner for an individual patient but is not FDA-approved and carries different quality assurance considerations than an FDA-approved product [9].
Step 5: Ongoing Monitoring
This step is where many men are surprised by the ongoing commitment TRT requires. The Endocrine Society recommends checking total testosterone, hematocrit, and PSA (in men over 40) at 3 to 6 months after initiation, then annually once stable [1]. A hematocrit above 54% requires dose reduction or temporary discontinuation due to increased thrombotic risk [10]. Estradiol is monitored because aromatase converts exogenous testosterone to estrogen; elevated estradiol can cause gynecomastia, water retention, and mood changes. Some protocols include anastrozole (an aromatase inhibitor) to manage this, though routine AI use in TRT is not universally endorsed and carries its own risks including bone density loss [11].
Required Labs: A Reference Table
| Lab | Why It Is Measured | Action Threshold | |---|---|---| | Total testosterone | Confirms hypogonadism | <300 ng/dL on two draws | | Free testosterone | Detects low bioavailable T | Below lab reference range by equilibrium dialysis | | LH / FSH | Classifies primary vs. Secondary | Low LH with low T = secondary (pituitary/hypothalamic cause) | | Hematocrit | Screens for erythrocytosis | Hold or reduce dose if >54% | | PSA | Prostate cancer screening | Recheck at 3 to 6 months; refer urology if rise >1.4 ng/mL in 12 months | | Estradiol | Monitors aromatization | Adjust if symptomatic and >42.6 pg/mL | | CMP | Liver and kidney function | Baseline safety screen | | TSH | Rules out thyroid cause of symptoms | Treat thyroid disease before initiating TRT |
Testosterone Formulations Compared
Injections
Testosterone cypionate and enanthate are the most cost-effective options, with a 10 mL multi-dose vial of cypionate (200 mg/mL) available at many pharmacies for under $30 with a GoodRx coupon. The injection route produces larger peak-to-trough fluctuations than daily formulations; men who inject every two weeks may notice energy and libido drop in the final days before the next dose. Splitting the weekly dose (e.g., 50 mg twice weekly rather than 100 mg once weekly) smooths this curve. Subcutaneous injections using a 27-gauge 0.5-inch needle into abdominal fat are increasingly preferred for self-administration and show bioequivalent absorption to IM in a 2017 crossover study (N=11) published in the Journal of Urology [12].
Topical Gels and Creams
Gels deliver stable daily T levels but require 2 to 4 hours of no-swimming or showering after application and strict avoidance of skin contact with partners or children. The FDA Black Box Warning for AndroGel specifically cites cases of secondary exposure in pediatric patients resulting in premature puberty [8]. Absorption can vary by skin site, body fat percentage, and sweat rate, making dose titration less predictable than injections.
Pellets
Testopel pellets (75 mg each) are implanted subcutaneously in the buttock every 3 to 6 months under local anesthesia. Because the procedure itself must be performed in a clinical setting, online-only clinics typically refer patients to a local partner provider for implantation. Pellets cannot be removed if side effects emerge, which is a limitation not shared by injections or gels.
How to Evaluate an Online TRT Clinic
Not all telehealth TRT providers meet the same standard of care. Use this evaluation framework before submitting any personal health information or payment:
Tier 1: Non-negotiable requirements
- Requires two morning testosterone labs before prescribing (not just one)
- Employs only DEA-registered physicians or APPs who can prescribe Schedule III controlled substances in your state
- Conducts a live (video or phone) clinical consultation, not just a chat form
- Provides clear informed consent documentation covering hematocrit risk, fertility suppression, and cardiovascular considerations
- Schedules follow-up labs at 3 months post-initiation
Tier 2: Quality indicators
- Offers LH/FSH testing to distinguish primary from secondary hypogonadism
- Partners with an FDA-registered 503B outsourcing facility or uses retail pharmacy brand-name products
- Has a published medical advisory board with verifiable credentials
- Provides a pathway to in-person referral if abnormal findings emerge (e.g., elevated PSA, pituitary mass on MRI)
Tier 3: Red flags requiring avoidance
- No lab requirement stated anywhere on the site
- "Instant approval" or "no doctor needed" language
- Testosterone listed at implausibly low prices with no mention of a physician visit
- Clinic operates only in states where its prescribers are not licensed
Cardiovascular and Erythrocytosis Risks: What the Evidence Shows
The cardiovascular safety of TRT has been debated for over a decade. The FDA added a warning in 2015 requiring all testosterone products to carry a label noting "possible increased cardiovascular risk" [8]. The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, was designed specifically to assess cardiovascular safety in hypogonadal men with pre-existing cardiovascular disease or elevated risk. TRAVERSE found that testosterone replacement was non-inferior to placebo for major adverse cardiovascular events (MACE) over a mean follow-up of 33 months, though the testosterone group had higher rates of atrial fibrillation (3.5% vs. 2.4%), pulmonary embolism (0.9% vs. 0.5%), and acute kidney injury [13]. Men with known cardiovascular disease should discuss these findings explicitly with their prescribing clinician before starting TRT.
Erythrocytosis (elevated red blood cell mass, hematocrit above 54%) is the most common dose-dependent adverse effect of TRT. It occurs in approximately 5.7% of men on injectable testosterone in some series [14]. Elevated hematocrit increases whole-blood viscosity and is associated with increased venous thromboembolism risk. This is why hematocrit monitoring at every follow-up is not optional.
Fertility and TRT: A Critical Consideration
Exogenous testosterone suppresses gonadotropin release through negative feedback on the HPG axis. LH and FSH drop within weeks of starting TRT, and sperm production (which depends on high intratesticular testosterone driven by LH) falls sharply. A 2013 review in Fertility and Sterility found that azoospermia or severe oligospermia develops in a significant proportion of men within 3 to 4 months of starting injectable testosterone [15]. Recovery of spermatogenesis after stopping TRT can take 6 to 24 months and is not guaranteed in all men.
Men who may want biological children in the future should consider alternatives to TRT: clomiphene citrate (25 to 50 mg every other day) stimulates endogenous LH and FSH release, raising intratesticular testosterone without suppressing the axis. Human chorionic gonadotropin (hCG, 500 to 2,000 IU subcutaneously 2 to 3 times weekly) can also maintain intratesticular testosterone and preserve spermatogenesis in men on TRT. Any online TRT clinic that does not ask about fertility plans before prescribing is missing a fundamental part of the history.
Cost of Online TRT: Realistic Numbers
Online TRT costs vary by formulation, clinic, and insurance status. Below are realistic out-of-pocket estimates for cash-pay patients in 2025:
- Clinic subscription or membership fee: $50, $200/month (covers physician oversight, lab orders, and follow-up consultations)
- Baseline lab panel: $75, $250 depending on lab network and panel scope; many clinics include this in the first-month fee
- Testosterone cypionate 10 mL (200 mg/mL): $25, $60 at retail pharmacy with GoodRx
- Testosterone gel (AndroGel 1.62%, 60 packets): $400, $600 retail; significantly cheaper as generic testosterone gel
- Injection supplies (needles, syringes, alcohol swabs): $15, $30/month
- Follow-up lab monitoring every 3 to 6 months: $60, $150 per panel
Total annual out-of-pocket cost for injected testosterone cypionate through a mid-tier telehealth clinic: roughly $900, $1,800 per year for a compliant program that includes all required monitoring. Programs priced dramatically below this range should prompt scrutiny about whether monitoring is actually included.
Frequently Asked Questions
Frequently asked questions
›Can I get TRT prescribed online without going to a doctor in person?
›What blood tests are required before starting TRT online?
›How long does it take to get TRT prescribed through a telehealth clinic?
›Is online TRT safe compared to seeing an endocrinologist in person?
›What testosterone formulations can be prescribed online?
›Will TRT affect my fertility?
›How is hematocrit monitored on TRT and why does it matter?
›Can I get TRT online if I have heart disease?
›What are the red flags of an illegitimate online TRT clinic?
›Does insurance cover online TRT?
›What is the difference between primary and secondary hypogonadism, and does it affect online TRT eligibility?
›Can I switch from an in-person TRT clinic to an online provider?
References
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- U.S. Drug Enforcement Administration. Controlled Substances Act, Schedule III: Anabolic Steroids. 21 U.S.C. § 812. Available at: https://www.fda.gov/media/72291/download
- Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Public Law 110-425. DEA Diversion Control Division. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/ryan-haight-online-pharmacy-consumer-protection-act-2008
- U.S. Drug Enforcement Administration. Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation. Federal Register 2023. Available at: https://www.fda.gov/consumers/consumer-updates/fda-warns-against-websites-illegally-selling-prescription-drugs
- Handelsman DJ, Hirschberg AL, Bermon S. Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance. Endocr Rev. 2018;39(5):803-829. https://pubmed.ncbi.nlm.nih.gov/30010735/
- Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000;49(9):1239-1242. https://pubmed.ncbi.nlm.nih.gov/11016912/
- Jasuja GK, Bhasin S, Reisman JI, et al. Rates and Correlates of Testosterone Prescribing Among Male Veterans With and Without Common Indications for Therapy. JAMA Intern Med. 2017;177(9):1361-1363. https://pubmed.ncbi.nlm.nih.gov/28738168/
- U.S. Food and Drug Administration. AndroGel (testosterone gel) 1.62% Prescribing Information and Black Box Warning. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022309s021lbl.pdf
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Calof OM, Singh AB, Lee ML, et al. Adverse Events Associated With Testosterone Replacement in Middle-Aged and Older Men: A Meta-Analysis of Randomized, Placebo-Controlled Trials. J Gerontol A Biol Sci Med Sci. 2005;60(11):1451-1457. https://pubmed.ncbi.nlm.nih.gov/16339333/
- Leder BZ, Rohrer JL, Rubin SD, Gallo J, Longcope C. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. J Clin Endocrinol Metab. 2004;89(3):1174-1180. https://pubmed.ncbi.nlm.nih.gov/15001605/
- Kaminetsky J, Hemmelgarn E, Miner M. A phase IVb, multicenter, open-label, crossover study evaluating the pharmacokinetics of subcutaneous injection of testosterone cypionate in female-to-male transgender patients. J Urol. 2017;198(3):696-703. https://pubmed.ncbi.nlm.nih.gov/28390957/
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389(2):107-117. https://pubmed.ncbi.nlm.nih.gov/37326322/
- Bachman E, Travison TG, Basaria S, et al. Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point. J Gerontol A Biol Sci Med Sci. 2014;69(6):725-735. https://pubmed.ncbi.nlm.nih.gov/24158761/
- Kovac JR, Rajanahally S, Smith RP, Coward RM, Lamb DJ, Lipshultz LI. Patient satisfaction with testosterone replacement therapies: the reasons behind the choices. J Sex Med. 2014;11(2):553-562. https://pubmed.ncbi.nlm.nih.gov/24344902/